Skip to main content
. 2020 Dec 17;23(3):362–369a. doi: 10.1093/europace/euaa298

Table 1.

Baseline patient characteristics (ITT population)

Characteristic a RF ablation (n = 128) AAD (n = 127) Total (N = 255)
Age, mean ± SD (years) 67.8 ± 4.8 67.6 ± 4.6 67.7 ± 4.7
Male sex 54 (42.2) 53 (41.7) 107 (42.0)
Months since first experience of AF, median (range) 51.2 (19–625) 49.8 (25–366) 50.3 (19–625)
Number of AF/AT episodes during prior 6 months, median (range) 6.5 (2–180) 6.0 (0–180) 6.0 (0–180)
Lone AF 38 (29.7) 39 (30.7) 77 (30.2)
HATCH score,b mean ± SD 1.5 ± 0.9 1.7 ± 0.9 1.6 ± 0.9
Congestive heart failure 24 (18.8) 27 (21.3) 51 (20.0)
Hypertension 120 (93.8) 123 (96.9) 243 (95.3)
Cardiomyopathyc 6 (4.7) 2 (1.6) 8 (3.1)
Left ventricular hypertrophy 26 (20.3) 23 (18.1) 49 (19.2)
Atrial flutter 15 (11.7) 10 (7.9) 25 (9.8)
Diabetes 13 (10.2) 14 (11.0) 27 (10.6)
Hyperlipidaemia/dyslipidaemia 67 (52.3) 67 (52.8) 134 (52.5)
Renal insufficiency 3 (2.3) 4 (3.1) 7 (2.7)
Transient ischaemic attack/stroke 12 (9.4) 8 (6.3) 20 (7.8)
AAD class I/III at baseline 61 (47.7) 69 (54.3) 130 (51.0)
Left ventricular ejection fraction, mean ± SD (%) 61.8 ± 5.8 62.3 ± 5.2 62.0 ± 5.5
Left atrial diameter, mean ± SD (mm) 42.1 ± 6.1 43.4 ± 5.6 42.7 ± 5.9

AAD, antiarrhythmic drug; AF, atrial fibrillation; AT, atrial tachycardia; ITT, intent-to-treat; RF, radiofrequency; SD, standard deviation.

a

Data are number of patients (%) unless otherwise specified.

b

HATCH score was calculated as: hypertension = 1 point, age >75 years = 1 point, transient ischaemic attack or stroke = 2 points, chronic obstructive pulmonary disease = 1 point, and heart failure = 2 points.

c

Includes ischaemic, non-ischaemic dilated, and hypertrophic obstructive cardiomyopathy.